"Simple is best", as Quotient plans US advance with Quo-Test POC diabetes test
This article was originally published in Clinica
Executive Summary
UK firm Quotient Diagnostics, a small company formed three years ago to exploit technology licensed from Barts and the London NHS trust, is preparing for US launch of its first product, an A1c test, in mid-2007.